← All trials
NCT05208710
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 23, 2022
- Primary completion
- Aug 31, 2023
- Completion date
- Aug 31, 2023
- First posted
- Jan 26, 2022
- Last posted
- Oct 28, 2022
- Enrollment
- 45
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- German Cancer Research CenterLead sponsor
- Heidelberg UniversityOverall official - principal investigator
- University of HeidelbergCollaborator
- University of HeidelbergCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.